lorazepam has been researched along with kainic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Bonnel, G; De Montigny, C | 1 |
| Diaz-Hernandez, M; Engel, T; Garcia-Huerta, P; Gomez-Villafuertes, R; Henshall, DC; Mesuret, G; Miras-Portugal, MT; Sanz-Rodriguez, A; Tanaka, K | 1 |
| Diviney, M; Henshall, DC; Reynolds, JP | 1 |
| Dhamne, SC; Gersner, R; Pascual-Leone, A; Rotenberg, A; Zangen, A | 1 |
| Bauer, S; Costard, L; Kienzler-Norwood, F; Müller, P; Neubert, V; Norwood, BA; Rosenow, F; Sadangi, C | 1 |
5 other study(ies) available for lorazepam and kainic acid
| Article | Year |
|---|---|
Benzodiazepine selectively antagonize kainate-induced activation in the rat hippocampus.
Topics: Acetylcholine; Animals; Anti-Anxiety Agents; Benzodiazepinones; Chlorpromazine; Diazepam; Flumazenil; Glutamates; Hippocampus; Injections, Intravenous; Iontophoresis; Kainic Acid; Lorazepam; Male; Phenobarbital; Pyramidal Tracts; Pyrrolidines; Rats; Rats, Inbred Strains | 1983 |
Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice.
Topics: Adenosine Triphosphate; Animals; Anticonvulsants; Cells, Cultured; Excitatory Amino Acid Agonists; Glutamic Acid; Hippocampus; Interleukin-1beta; Kainic Acid; Lorazepam; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Neurons; Neuroprotective Agents; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Seizures; Status Epilepticus | 2012 |
Comparison of short-term effects of midazolam and lorazepam in the intra-amygdala kainic acid model of status epilepticus in mice.
Topics: Amygdala; Animals; Anticonvulsants; Benzodiazepines; Disease Models, Animal; Hippocampus; Kainic Acid; Lorazepam; Male; Mice; Mice, Inbred C57BL; Midazolam; Status Epilepticus; Treatment Outcome | 2015 |
Bursts of high-frequency repetitive transcranial magnetic stimulation (rTMS), together with lorazepam, suppress seizures in a rat kainate status epilepticus model.
Topics: Animals; Anticonvulsants; Combined Modality Therapy; Disease Models, Animal; Kainic Acid; Lorazepam; Rats; Seizures; Status Epilepticus; Transcranial Magnetic Stimulation; Treatment Outcome | 2016 |
A novel animal model of acquired human temporal lobe epilepsy based on the simultaneous administration of kainic acid and lorazepam.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Temporal Lobe; Excitatory Amino Acid Agonists; Hippocampus; Humans; Kainic Acid; Lorazepam; Male; Mossy Fibers, Hippocampal; Neurodegenerative Diseases; Rats; Rats, Sprague-Dawley; Sclerosis; Video Recording | 2017 |